title: Is there a survival benefit from increased intensity of CEA monitoring after primary resection of colorectal cancer?
authors.affiliation: Clinical Operational Research Unit, University College London, London, UK; Clinical Trials Group, University College London, London, UK. Electronic address: tom.treasure@gmail.com.
authors.forename: T
authors.initials: T
authors.lastname: Treasure
authors.affiliation: Wales Cancer Trials Unit, Cardiff University, Cardiff, UK.
authors.forename: F
authors.initials: F
authors.lastname: Macbeth
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D002277:Carcinoma / Q000601:surgery*; D003082:Colectomy; D015179:Colorectal Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*
chemical_list: D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen